Aclarion Stock In The News

ACON Stock  USD 0.18  0.01  5.88%   
Our overall analysis of Aclarion's news coverage and content from conventional and social sources shows investors' bearish mood towards Aclarion. The specific impact of Aclarion news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Aclarion's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Aclarion headlines in addition to utilizing other, more conventional financial analysis modules. Check out Aclarion Backtesting and Aclarion Hype Analysis.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.

Aclarion Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
https://www.globenewswire.com/news-release/2023/11/27/2786102/0/en/Aclarion-Announces-Key-Commercial-Milestone-With-Completion-of-1-000-Nociscan-Exams.html
 Neutral
Macroaxis News: globenewswire.com
Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption
https://www.globenewswire.com/news-release/2023/11/08/2776185/0/en/Aclarion-Announces-Achievement-of-Goal-to-Enroll-10-Leading-Spine-Surgery-Key-Opinion-Leaders-KOLs-to-Support-Nociscan-Adoption.html
 Bullish
Macroaxis News: globenewswire.com
Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD
https://www.globenewswire.com/news-release/2023/11/06/2774042/0/en/Aclarion-Expands-Immediate-Nociscan-Access-Into-New-York-City-With-Tenth-Key-Opinion-Leader-Surgeon-Advisor-Addition-Roger-Hartl-MD.html
 Neutral
Macroaxis News: globenewswire.com
Aclarion Presents at the NIH HEAL Initiative Fall Meeting
https://www.globenewswire.com/news-release/2023/11/01/2771128/0/en/Aclarion-Presents-at-the-NIH-HEAL-Initiative-Fall-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver
https://www.globenewswire.com/news-release/2023/10/25/2766514/0/en/Aclarion-Announces-Signing-of-Commercial-Agreement-With-Porter-Hospital-an-AdventHealth-facility-to-Bring-Nociscan-Technology-to-Denver.html
 Neutral
Macroaxis News: globenewswire.com
Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting
https://www.globenewswire.com/news-release/2023/10/24/2765652/0/en/Aclarion-Announces-Nociscan-Cost-Effectiveness-Poster-Presented-at-45th-Annual-SMDM-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan
https://www.globenewswire.com/news-release/2023/10/23/2764570/0/en/Aclarion-Announces-Signing-Strategic-Partnership-Letter-of-Intent-With-ATEC-to-Advance-Commercialization-of-Nociscan.html
 Bullish
Macroaxis News: globenewswire.com
Aclarion Provides Updated Investor Presentation and Corporate Update
https://www.globenewswire.com/news-release/2023/10/02/2752713/0/en/Aclarion-Provides-Updated-Investor-Presentation-and-Corporate-Update.html
 Bullish
Macroaxis News: globenewswire.com
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
https://www.globenewswire.com/news-release/2023/08/25/2732147/0/en/Aclarion-Inc-Announces-Filing-of-Delayed-10-Q-Quarterly-Report.html
 Neutral
Macroaxis News: globenewswire.com
Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
https://www.globenewswire.com/news-release/2023/06/14/2688289/0/en/Aclarion-Announces-New-Commercial-Engagement-with-The-Imaging-Center-Grand-Rapids-MI.html
 Neutral

Aclarion Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Aclarion and other traded companies coverage with news coverage. We help investors stay connected with Aclarion headlines for the 1st of December to make an informed investment decision based on correlating the impacts of news items on Aclarion Stock performance. Please note that trading solely based on the Aclarion hype is not for everyone as timely availability and quick action are needed to avoid losses.
Aclarion's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Aclarion investors visualize upcoming and past events in order to time the market based on Aclarion noise-free hype analysis.
Aclarion stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Aclarion earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Aclarion that are available to investors today. That information is available publicly through Aclarion media outlets and privately through word of mouth or via Aclarion internal channels. However, regardless of the origin, that massive amount of Aclarion data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aclarion news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aclarion relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aclarion's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aclarion alpha.

Aclarion Largest EPS Surprises

Earnings surprises can significantly impact Aclarion's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-14
2023-09-30-0.09-0.117-0.02730 
2024-09-30
2024-09-30-0.18-0.150.0316 
2023-07-03
2023-06-30-0.1-0.15-0.0550 
2024-08-23
2024-06-30-0.23-0.150.0834 
2022-11-14
2022-09-30-0.12-0.21-0.0975 
2024-05-15
2024-03-31-0.57-0.440.1322 
View All Earnings Estimates

Aclarion Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Aclarion Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
Investing News at Macroaxis
27th of November 2024
Aclarion extends equity line agreement, issues new shares
at investing.com 
news
14th of November 2024
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
at accesswire.com 
prnewswire News
4th of November 2024
ACON Invests in Mexican Fitness Studio Chain Commando
at prnewswire.com 
Macroaxis News: globenewswire.com
10th of October 2024
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
at globenewswire.com 
Google News at Macroaxis
24th of September 2024
Aclarion, Inc. initiates 10 million at-the-market offering - Investing.com
at news.google.com 
Yahoo News
13th of September 2024
PRISM MarketView Showcases Aclarion Disrupting Chronic Pain Treatment with Nociscan AI Tec...
at finance.yahoo.com 
Yahoo News
6th of September 2024
Aclarion Added to PRISM Emerging Medical Devices Index
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aclarion in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aclarion's short interest history, or implied volatility extrapolated from Aclarion options trading.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports:
Check out Aclarion Backtesting and Aclarion Hype Analysis.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.40)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.36)
Return On Assets
(1.15)
Return On Equity
(7.14)
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.